Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v14-FR | Version v3-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2019-02-28 | 2019-01-15 |
| Drug Identification Number | 02443724 | 02443724 |
| Brand name | VIIBRYD | VIIBRYD |
| Common or Proper name | VIIBRYD 10MG TAB 30 CA | VIIBRYD 10MG TAB 30 CA |
| Company Name | ABBVIE CORPORATION | ABBVIE CORPORATION |
| Ingredients | VILAZODONE HYDROCHLORIDE | VILAZODONE HYDROCHLORIDE |
| Strength(s) | 10MG | 10MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL | ORAL |
| Packaging size | 10MG TAB 30 CA | 10MG TAB 30 CA |
| ATC code | N06AX | N06AX |
| ATC description | ||
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2019-01-25 | 2019-01-28 |
| Actual start date | 2019-01-25 | |
| Estimated end date | 2019-02-28 | 2019-05-20 |
| Actual end date | 2019-02-27 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Actively working with supplier to pull forward the next replenishment and improve recovery date. In communication with Health Canada drug shortage unit on options to mitigate impact of shortage on patients. | Actively working with supplier to pull forward the next replenishment and improve recovery date. In communication with Health Canada drug shortage unit on options to mitigate impact of shortage on patients. |
| Health Canada comments |